MPMario Ponce

Mario Ponce

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mario Ponce has a total of 22 co-authors. Here are the top co-authors by number of shared publications:

  • Anny D Rodriguez

    Clinical Research Center, Morehouse School of Medicine, Atlanta, GA, USA

    1 shared publication
  • Christopher S Awad

    Clinical Research Center, Morehouse School of Medicine, Atlanta, GA, USA

    1 shared publication
  • Ciro Peregrino Maguiña Vargas

    Aguda Hospital Nacional Cayetano Heredia hospitalizados en el Hospital Nacional Cayetano Heredia entre 1993 y 2006. Resultados: La edad promedio fue 27 8 años 7% fueron varones 72

    1 shared publication
  • Damien Mikael Hansra

    Cancer Treatment Centers of America, Atlanta, GA

    1 shared publication
  • Edgardo S. Santos

    The Oncology Institute of Hope and Innovation, Fort Lauderdale, FL, USA

    1 shared publication
  • Eric L Flenaugh

    Pulmonary and Critical Care Medicine Division, Department of Medicine, Morehouse School of Medicine, Atlanta, GA, USA

    1 shared publication

Latest Publications

  • Open Access

    Race Adjustment of Pulmonary Function Tests in the Diagnosis and Management of COPD: A Scoping Review

    by Sean Richard Davidson, Muhammed Y Idris, Christopher S Awad, Marshaleen Henriques King, Gloria E Westney, Mario Ponce, Anny D Rodriguez, Kim L Lipsey, Eric L Flenaugh, Marilyn G Foreman

    Aim: Increasing evidence suggests that the inclusion of self-identified race in clinical decision algorithms may perpetuate longstanding inequities. Until recently, most pulmonary function tests utilized separate reference equations that are race/ethnicity based. Purpose: We assess the magnitude and scope of the available literature on the negative impact of race-based pulmonary function prediction equations on relevant outcomes in African Americans with COPD. Methods: We performed a scoping review utilizing an English language search on PubMed/Medline, Embase, Scopus, and Web of Science in September 2022 and updated it in December 2023. We searched for publications regarding the effect of race-specific vs race-neutral, race-free, or race-reversed lung function testing algorithms on the diagnosis of COPD and COPD-related physiologic and functional measures. Joanna Briggs Institute (JBI) guidelines were utilized for this scoping review. Eligibility criteria: The search was restricted to adults with COPD. We excluded publications on other lung disorders, non-English language publications, or studies that did not include African Americans. The search identified publications. Ultimately, six peer-reviewed publications and four conference abstracts were selected for this review. Results: Removal of race from lung function prediction equations often had opposite effects in African Americans and Whites, specifically regarding the severity of lung function impairment. Symptoms and objective findings were better aligned when race-specific reference values were not used. Race-neutral prediction algorithms uniformly resulted in reclassifying severity in the African Americans studied. Conclusion: The limited literature does not support the use of race-based lung function prediction equations. However, this assertion does not provide guidance for every specific clinical situation. For African Americans with COPD, the use of race-based prediction equations appears to fall short in enhancing diagnostic accuracy, classifying severity of impairment, or predicting subsequent clinical events. We do not have information comparing race-neutral vs race-based algorithms on prediction of progression of COPD. We conclude that the elimination of race-based reference values potentially reduces underestimation of disease severity in African Americans with COPD.


  • Pulmonary blastoma: a clinicopathologic study of 3 cases and review of literature

    by Damien M. Hansra, Mario Ponce, Jose D. Sandoval-Sus, Maureen Cioffi-Lavina, Ravi Patel, Ikpat F. Offiong, Edgardo S. Santos


  • Open Access

    Manifestaciones clínicas y complicaciones de la fase aguda de bartonelosis o Fiebre de la Oroya en pacientes atendidos en el Hospital Nacional Cayetano Heredia.

    by Ciro Peregrino Maguiña Vargas, Renzo Benigno Peña Collantes, Mario Carlos Ponce Alvarez, Teófilo Fernando Quispe- Chullo, Palmira Ryquett Ventosilla López

    Objetivos: Determinar las características clínicas, epidemiológicas y de laboratorio de la bartonelosis aguda, así como las complicaciones en una serie de pacientes atendidos en el Hospital Nacional Cayetano Heredia. Material y métodos: Estudio descriptivo de tipo serie de casos de pacientes mayores de 15 años con bartonelosis aguda hospitalizados en el Hospital Nacional Cayetano Heredia entre 1993 y 2006. Resultados: La edad promedio fue 27,8 años, 72,7% fueron varones, 51,5% procedía de Lima y 33,3% de Ancash. Los síntomas principales fueron: fiebre 90,9%, cefalea 87,9%, hiporexia 75,5%, baja de peso 63,6%, e ictericia 57,6%. Dos pacientes presentaron alteraciones en el fondo de ojo: retinitis exudativa y retinopatía hemorrágica. El hematocrito promedio fue 20,8% y 63,6% cursaron hematocrito ≤20%. Hubo desviación izquierda en 24,2%, hiperbilirrubinemia a predominio indirecto 62,5% e hipoalbuminemia (< 3mg/dl) 56,5%. Se presentaron complicaciones en 84,8%, el 27,2% requirió internamiento en UCI. Las complicaciones no infecciosas ocurrieron en 84,8%, hematológicas 81,8% y gastrointestinales 78,7%. Las complicaciones infecciosas se presentaron en 12,1%. Los antibióticos más utilizados fueron ciprofloxacina 66,6% y cloranfenicol 42,4%, se administró corticoides en 9,1% y se transfundió paquete globular en 42,4%. Conclusiones: Los pacientes de UCI tuvieron más complicaciones cardiovasculares, trombocitopenia y mayor severidad de la anemia. No se registró mortalidad.